{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:40:55Z","timestamp":1784292055863,"version":"3.55.0"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T00:00:00Z","timestamp":1566777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T00:00:00Z","timestamp":1566777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11010-019-03617-5","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T15:06:19Z","timestamp":1566831979000},"page":"133-155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":138,"title":["Melatonin and its ubiquitous anticancer effects"],"prefix":"10.1007","volume":"462","author":[{"given":"Sankha","family":"Bhattacharya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna Kumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Dehari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish Kumar","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,26]]},"reference":[{"key":"3617_CR1","doi-asserted-by":"crossref","first-page":"28531","DOI":"10.1016\/S0021-9258(19)61934-4","volume":"269","author":"M Becker-Andr\u00e9","year":"1994","unstructured":"Becker-Andr\u00e9 M, Wiesenberg I, Schaeren-Wiemers N, Andr\u00e9 E, Missbach M, Saurat JH, Carlberg C (1994) Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem 269:28531\u201328534","journal-title":"J Biol Chem"},{"key":"3617_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000225117","volume":"33","author":"V Lapin","year":"1976","unstructured":"Lapin V, Ebels I (1976) Effects of some low molecular weight sheep pineal fractions and melatonin on different tumors in rats and mice. Oncology 33:110\u2013113. https:\/\/doi.org\/10.1159\/000225117","journal-title":"Oncology"},{"key":"3617_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/2193-1801-2-158","volume":"2","author":"B Iyengar","year":"2013","unstructured":"Iyengar B (2013) The melanocyte photosensory system in the human skin. SpringerPlus 2:158. https:\/\/doi.org\/10.1186\/2193-1801-2-158","journal-title":"SpringerPlus"},{"key":"3617_CR4","first-page":"613","volume":"29","author":"S Sensi","year":"1993","unstructured":"Sensi S, Pace Palitti V, Guagnano MT (1993) Chronobiology in endocrinology. Ann Ist Super Sanita 29:613\u2013631","journal-title":"Ann Ist Super Sanita"},{"key":"3617_CR5","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1111\/bph.14116","volume":"175","author":"N Zisapel","year":"2018","unstructured":"Zisapel N (2018) New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. Br J Pharmacol 175:3190\u20133199. https:\/\/doi.org\/10.1111\/bph.14116","journal-title":"Br J Pharmacol"},{"key":"3617_CR6","doi-asserted-by":"publisher","first-page":"e0146643","DOI":"10.1371\/journal.pone.0146643","volume":"11","author":"JK Paulose","year":"2016","unstructured":"Paulose JK, Wright JM, Patel AG, Cassone VM (2016) Human gut bacteria are sensitive to melatonin and express endogenous circadian rhythmicity. PLoS ONE 11:e0146643. https:\/\/doi.org\/10.1371\/journal.pone.0146643","journal-title":"PLoS ONE"},{"key":"3617_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.neuron.2012.04.006","volume":"74","author":"U Albrecht","year":"2012","unstructured":"Albrecht U (2012) Timing to perfection: the biology of central and peripheral circadian clocks. Neuron 74:246\u2013260. https:\/\/doi.org\/10.1016\/j.neuron.2012.04.006","journal-title":"Neuron"},{"key":"3617_CR8","first-page":"205","volume-title":"Melatonin: an introduction to its physiological and pharmacological effects in humans","author":"B Claustrat","year":"2014","unstructured":"Claustrat B (2014) Melatonin: an introduction to its physiological and pharmacological effects in humans. Springer, Berlin, pp 205\u2013219"},{"key":"3617_CR9","doi-asserted-by":"publisher","first-page":"23448","DOI":"10.3390\/ijms151223448","volume":"15","author":"MA Bonmati-Carrion","year":"2014","unstructured":"Bonmati-Carrion MA, Arguelles-Prieto R, Martinez-Madrid MJ, Reiter R, Hardeland R, Rol MA, Madrid JA (2014) Protecting the melatonin rhythm through circadian healthy light exposure. Int J Mol Sci 15:23448\u201323500. https:\/\/doi.org\/10.3390\/ijms151223448","journal-title":"Int J Mol Sci"},{"key":"3617_CR10","doi-asserted-by":"publisher","first-page":"3271948","DOI":"10.1155\/2018\/3271948","volume":"2018","author":"J Men\u00e9ndez-Men\u00e9ndez","year":"2018","unstructured":"Men\u00e9ndez-Men\u00e9ndez J, Mart\u00ednez-Campa C (2018) Melatonin: an anti-tumor agent in hormone-dependent cancers. Int J Endocrinol 2018:3271948. https:\/\/doi.org\/10.1155\/2018\/3271948","journal-title":"Int J Endocrinol"},{"key":"3617_CR11","unstructured":"Latest Global Cancer Data (2018) Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. WHO 12 September 2018, 16h00\u00a0pm Geneva time pp 1\u20133"},{"key":"3617_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/pros.20155","volume":"63","author":"RM Sainz","year":"2005","unstructured":"Sainz RM, Mayo JC, Tan D-x, Le\u00f3n J, Manchester L, Reiter RJ (2005) Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism. Prostate 63:29\u201343. https:\/\/doi.org\/10.1002\/pros.20155","journal-title":"Prostate"},{"key":"3617_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1600-079X.2006.00315.x","volume":"40","author":"C Mart\u00ednez-Campa","year":"2006","unstructured":"Mart\u00ednez-Campa C, Alonso-Gonz\u00e1lez C, Mediavilla MD, Cos S, Gonz\u00e1lez A, Ramos S, S\u00e1nchez-Barcel\u00f3 EJ (2006) Melatonin inhibits both ER\u03b1 activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium. J Pineal Res 40:291\u2013296. https:\/\/doi.org\/10.1111\/j.1600-079X.2006.00315.x","journal-title":"J Pineal Res"},{"key":"3617_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3109\/09513590.2013.849238","volume":"30","author":"RJ Reiter","year":"2014","unstructured":"Reiter RJ, Tan D-X, Tamura H, Cruz MHC, Fuentes-Broto L (2014) Clinical relevance of melatonin in ovarian and placental physiology: a review. Gynecol Endocrinol 30:83\u201389. https:\/\/doi.org\/10.3109\/09513590.2013.849238","journal-title":"Gynecol Endocrinol"},{"key":"3617_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1600-079X.2006.00407.x","volume":"42","author":"D-X Tan","year":"2006","unstructured":"Tan D-X, Manchester LC, Terron MP, Flores LJ, Reiter RJ (2006) One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 42:28\u201342. https:\/\/doi.org\/10.1111\/j.1600-079X.2006.00407.x","journal-title":"J Pineal Res"},{"key":"3617_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00249","author":"D Zhao","year":"2019","unstructured":"Zhao D, Yu Y, Shen Y, Liu Q, Zhao Z, Sharma R, Reiter RJ (2019) Melatonin synthesis and function: evolutionary history in animals and plants. Front Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2019.00249","journal-title":"Front Endocrinol"},{"key":"3617_CR17","first-page":"147","volume":"1","author":"O Ianas","year":"1991","unstructured":"Ianas O, Olnescu R, Badescu I (1991) Melatonin involvement in oxidative stress. Rom J Endocrinol 1:147\u2013153","journal-title":"Rom J Endocrinol"},{"key":"3617_CR18","first-page":"57","volume":"1","author":"DX Tan","year":"1993","unstructured":"Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ (1993) Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1:57\u201360","journal-title":"Endocr J"},{"key":"3617_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0304-3835(93)90076-L","volume":"70","author":"DX Tan","year":"1993","unstructured":"Tan DX, Poeggeler B, Reiter RJ, Chen LD, Chen S, Manchester LC, BarlowWalden LR (1993) The pineal hormone melatonin inhibits DNA adduct formationinduced by chemical carcinogen safrole in vivo. Cancer Lett 70:65\u201371","journal-title":"Cancer Lett"},{"key":"3617_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0891-5849(96)00046-9","volume":"21","author":"KA Marshall","year":"1996","unstructured":"Marshall KA, Reiter RJ, Poeggeler B, Aruoma OI, Halliwell B (1996) Evaluation of the antioxidant activity of melatonin in vitro. Free Radic Med 21:307\u2013315","journal-title":"Free Radic Med"},{"key":"3617_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1600-079X.2003.00092.x","volume":"36","author":"C Rodriguez","year":"2004","unstructured":"Rodriguez C, Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V, Reiter RJ (2004) Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 36:1\u20139","journal-title":"J Pineal Res"},{"key":"3617_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10540-007-9052-1","volume":"27","author":"DS Maharaj","year":"2007","unstructured":"Maharaj DS, Glass BD, Daya S (2007) Melatonin: new places in therapy. Biosci Rep 27:299\u2013320. https:\/\/doi.org\/10.1007\/s10540-007-9052-1","journal-title":"Biosci Rep"},{"key":"3617_CR23","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","volume":"332","author":"EK Rowinsky","year":"1995","unstructured":"Rowinsky EK, Donehower RC (1995) Paclitaxel (taxol). N Engl J Med 332:1004\u20131014. https:\/\/doi.org\/10.1056\/NEJM199504133321507","journal-title":"N Engl J Med"},{"key":"3617_CR24","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/bjc.1989.272","volume":"60","author":"SA Shellard","year":"1989","unstructured":"Shellard SA, Whelan RD, Hill BT (1989) Growth inhibitory and cytotoxic effects of melatonin and its metabolites on human tumour cell lines in vitro. Br J Cancer 60:288\u2013290","journal-title":"Br J Cancer"},{"key":"3617_CR25","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.3390\/ijms14022410","volume":"14","author":"G Di Bella","year":"2013","unstructured":"Di Bella G, Mascia F, Gualano L, Di Bella L (2013) Melatonin anticancer effects: review. Int J Mol Sci 14:2410","journal-title":"Int J Mol Sci"},{"key":"3617_CR26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/sj\/neo\/7900203","volume":"3","author":"RK Srivastava","year":"2001","unstructured":"Srivastava RK (2001) TRAIL\/Apo-2L: mechanisms and clinical applications in cancer. Neoplasia 3:535\u2013546. https:\/\/doi.org\/10.1038\/sj\/neo\/7900203","journal-title":"Neoplasia"},{"key":"3617_CR27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1124\/pr.110.002832","volume":"62","author":"ML Dubocovich","year":"2010","unstructured":"Dubocovich ML, Delagrange P, Krause DN, Sugden D, Cardinali DP, Olcese J (2010) International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev 62:343\u2013380. https:\/\/doi.org\/10.1124\/pr.110.002832","journal-title":"Pharmacol Rev"},{"key":"3617_CR28","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.18632\/oncotarget.2994","volume":"6","author":"J Chang","year":"2014","unstructured":"Chang J, Jiang L, Wang Y, Yao B, Yang S, Zhang B, Zhang M-Z (2014) 12\/15 Lipoxygenase regulation of colorectal tumorigenesis is determined by the relative tumor levels of its metabolite 12-HETE and 13-HODE in animal models. Oncotarget 6:2879\u20132888. https:\/\/doi.org\/10.18632\/oncotarget.2994","journal-title":"Oncotarget"},{"key":"3617_CR29","first-page":"4693","volume":"59","author":"DE Blask","year":"1999","unstructured":"Blask DE, Sauer LA, Dauchy RT, Holowachuk EW, Ruhoff MS, Kopff HS (1999) Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Can Res 59:4693","journal-title":"Can Res"},{"key":"3617_CR30","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/sj.mp.4001593","volume":"10","author":"PA Thomson","year":"2004","unstructured":"Thomson PA, Wray NR, Thomson AM, Dunbar DR, Grassie MA, Condie A, Walker MT, Smith DJ, Pulford DJ, Muir W, Blackwood DHR, Porteous DJ (2004) Sex-specific association between bipolar affective disorder in women and GPR50, an X-linked orphan G protein-coupled receptor. Mol Psychiatry 10:470. https:\/\/doi.org\/10.1038\/sj.mp.4001593","journal-title":"Mol Psychiatry"},{"key":"3617_CR31","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s13197-013-1221-6","volume":"51","author":"D Karunanithi","year":"2014","unstructured":"Karunanithi D, Radhakrishna A, Sivaraman KP, Biju VMN (2014) Quantitative determination of melatonin in milk by LC-MS\/MS. J Food Sci Technol 51:805\u2013812. https:\/\/doi.org\/10.1007\/s13197-013-1221-6","journal-title":"J Food Sci Technol"},{"key":"3617_CR32","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.2174\/092986710794183015","volume":"17","author":"MD Mediavilla","year":"2010","unstructured":"Mediavilla MD, Sanchez-Barcelo EJ, Tan DX, Manchester L, Reiter RJ (2010) Basic mechanisms involved in the anti-cancer effects of melatonin. Curr Med Chem 17:4462\u20134481","journal-title":"Curr Med Chem"},{"key":"3617_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5152\/eurasianjmed.2015.0267","volume":"48","author":"M Emet","year":"2016","unstructured":"Emet M, Ozcan H, Ozel L, Yayla M, Halici Z, Hacimuftuoglu A (2016) A review of melatonin, its receptors and drugs. Eurasian J Med 48:135\u2013141. https:\/\/doi.org\/10.5152\/eurasianjmed.2015.0267","journal-title":"Eurasian J Med"},{"key":"3617_CR34","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.sleep.2006.11.010","volume":"8","author":"Y-H Wu","year":"2007","unstructured":"Wu Y-H, Swaab DF (2007) Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer\u2019s disease. Sleep Med 8:623\u2013636. https:\/\/doi.org\/10.1016\/j.sleep.2006.11.010","journal-title":"Sleep Med"},{"key":"3617_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1743-7075-2-22","volume":"2","author":"R Hardeland","year":"2005","unstructured":"Hardeland R, Pandi-Perumal SR (2005) Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug. Nutr Metab 2:22. https:\/\/doi.org\/10.1186\/1743-7075-2-22","journal-title":"Nutr Metab"},{"key":"3617_CR36","doi-asserted-by":"publisher","first-page":"101185","DOI":"10.11131\/2015\/101185","volume":"2","author":"DN Cook","year":"2015","unstructured":"Cook DN, Kang HS, Jetten AM (2015) Retinoic acid-related orphan receptors (RORs): regulatory functions in immunity, development, circadian rhythm, and metabolism. Nucl Recept Res 2:101185. https:\/\/doi.org\/10.11131\/2015\/101185","journal-title":"Nucl Recept Res"},{"key":"3617_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/jpi.12010","volume":"54","author":"A Galano","year":"2013","unstructured":"Galano A, Tan D-X, Reiter R (2013) On the free radical scavenging activities of melatonin\u2019s metabolites, AFMK and AMK. J Pineal Res 54:245\u2013257","journal-title":"J Pineal Res"},{"key":"3617_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.18632\/genesandcancer.107","volume":"7","author":"J Lopes","year":"2016","unstructured":"Lopes J, Arnosti D, Trosko JE, Tai M-H, Zuccari D (2016) Melatonin decreases estrogen receptor binding to estrogen response elements sites on the OCT4 gene in human breast cancer stem cells. Genes Cancer 7:209\u2013217. https:\/\/doi.org\/10.18632\/genesandcancer.107","journal-title":"Genes Cancer"},{"key":"3617_CR39","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/sj.bjc.6605336","volume":"101","author":"C Mart\u00ednez-Campa","year":"2009","unstructured":"Mart\u00ednez-Campa C, Gonz\u00e1lez A, Mediavilla MD, Alonso-Gonz\u00e1lez C, Alvarez-Garc\u00eda V, S\u00e1nchez-Barcel\u00f3 EJ, Cos S (2009) Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells. Br J Cancer 101:1613. https:\/\/doi.org\/10.1038\/sj.bjc.6605336","journal-title":"Br J Cancer"},{"key":"3617_CR40","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1034\/j.1600-079X.2003.00077.x","volume":"35","author":"MM Leon-Blanco","year":"2003","unstructured":"Leon-Blanco MM, Guerrero JM, Reiter RJ, Calvo JR, Pozo D (2003) Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro. J Pineal Res 35:204\u2013211","journal-title":"J Pineal Res"},{"key":"3617_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2174\/1568026023394335","volume":"2","author":"JM Guerrero","year":"2002","unstructured":"Guerrero JM, Reiter RJ (2002) Melatonin-immune system relationships. Curr Top Med Chem 2:167\u2013179. https:\/\/doi.org\/10.2174\/1568026023394335","journal-title":"Curr Top Med Chem"},{"key":"3617_CR42","doi-asserted-by":"publisher","first-page":"8638","DOI":"10.3390\/ijms14048638","volume":"14","author":"A Carrillo-Vico","year":"2013","unstructured":"Carrillo-Vico A, Lardone PJ, Alvarez-S\u00e1nchez N, Rodr\u00edguez-Rodr\u00edguez A, Guerrero JM (2013) Melatonin: buffering the immune system. Int J Mol Sci 14:8638\u20138683. https:\/\/doi.org\/10.3390\/ijms14048638","journal-title":"Int J Mol Sci"},{"key":"3617_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2009.09.005","volume":"79","author":"FC Campbell","year":"2010","unstructured":"Campbell FC, Xu H, El-Tanani M, Crowe P, Bingham V (2010) The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control. Biochem Pharmacol 79:1\u20139. https:\/\/doi.org\/10.1016\/j.bcp.2009.09.005","journal-title":"Biochem Pharmacol"},{"key":"3617_CR44","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0024-3205(99)00262-3","volume":"65","author":"MD Mediavilla","year":"1999","unstructured":"Mediavilla MD, Cos S, Sanchez-Barcelo EJ (1999) Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sci 65:415\u2013420","journal-title":"Life Sci"},{"key":"3617_CR45","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3978\/j.issn.1000-9604.2012.09.03","volume":"24","author":"D Lv","year":"2012","unstructured":"Lv D, Cui P-L, Yao S-W, Xu Y-Q, Yang Z-X (2012) Melatonin inhibits the expression of vascular endothelial growth factor in pancreatic cancer cells. Chin J Cancer Res 24:310\u2013316. https:\/\/doi.org\/10.3978\/j.issn.1000-9604.2012.09.03","journal-title":"Chin J Cancer Res"},{"key":"3617_CR46","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.archoralbio.2011.03.004","volume":"56","author":"A Cutando","year":"2011","unstructured":"Cutando A, Aneiros-Fern\u00e1ndez J, L\u00f3pez-Valverde A, Arias-Santiago S, Aneiros-Cachaza J, Reiter RJ (2011) A new perspective in oral health: potential importance and actions of melatonin receptors MT1, MT2, MT3, and RZR\/ROR in the oral cavity. Arch Oral Biol 56:944\u2013950. https:\/\/doi.org\/10.1016\/j.archoralbio.2011.03.004","journal-title":"Arch Oral Biol"},{"key":"3617_CR47","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1177\/1947601913479022","volume":"3","author":"MC Casimiro","year":"2012","unstructured":"Casimiro MC, Crosariol M, Loro E, Li Z, Pestell RG (2012) Cyclins and cell cycle control in cancer and disease. Genes Cancer 3:649\u2013657. https:\/\/doi.org\/10.1177\/1947601913479022","journal-title":"Genes Cancer"},{"key":"3617_CR48","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1469-7793.2001.0581h.x","volume":"531","author":"CA Boyd","year":"2001","unstructured":"Boyd CA (2001) Amine uptake and peptide hormone secretion: aPUD cells in a new landscape. J Physiol 531:581. https:\/\/doi.org\/10.1111\/j.1469-7793.2001.0581h.x","journal-title":"J Physiol"},{"key":"3617_CR49","first-page":"11","volume":"56","author":"IM Kvetno\u012d","year":"1978","unstructured":"Kvetno\u012d IM, Ra\u012dkhlin NT (1978) Clinical pathology of the APUD system (apudopathy). Klin Med 56:11","journal-title":"Klin Med"},{"key":"3617_CR50","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/cej.0000000000000030","volume":"23","author":"WS Yang","year":"2014","unstructured":"Yang WS, Deng Q, Fan WY, Wang WY, Wang X (2014) Light exposure at night, sleep duration, melatonin, and breast cancer: a dose-response analysis of observational studies. Eur J Cancer Prev 23:269\u2013276. https:\/\/doi.org\/10.1097\/cej.0000000000000030","journal-title":"Eur J Cancer Prev"},{"key":"3617_CR51","first-page":"11","volume":"6","author":"Nadia A Abd","year":"2015","unstructured":"Abd Nadia A, El Moneim HEM, Sorial Mina Mamdouh, Hewala Taha I, Embaby Amira, Sheweita Salah (2015) A molecular case-control study on the Association of Melatonin Hormone and rs#10830963 Single nucleotide polymorphism in its receptor MTNR1B gene with breast cancer. Middle East J Cancer 6:11\u201320","journal-title":"Middle East J Cancer"},{"key":"3617_CR52","doi-asserted-by":"publisher","DOI":"10.4172\/2329-6771.S1-006","author":"D Cardinali","year":"2016","unstructured":"Cardinali D, Escames G, Acu\u00f1a-Castroviejo D, Ortiz Garcia F, Fernandez-Gil B, Guerra-Librero Rite A, Garc\u00eda S, Shen Y-Q, Florido J (2016) Melatonin-induced oncostasis, mechanisms and clinical relevance. J Integr Oncol. https:\/\/doi.org\/10.4172\/2329-6771.S1-006","journal-title":"J Integr Oncol"},{"key":"3617_CR53","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000363426","volume":"9","author":"M Basler","year":"2014","unstructured":"Basler M, Jetter A, Fink D, Seifert B, Kullak-Ublick GA, Trojan A (2014) Urinary excretion of melatonin and association with breast cancer: meta-analysis and review of the literature. Breast care (Basel, Switzerland) 9:182\u2013187. https:\/\/doi.org\/10.1159\/000363426","journal-title":"Breast care (Basel, Switzerland)"},{"key":"3617_CR54","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1600-079X.2011.00890.x","volume":"51","author":"CW Tam","year":"2011","unstructured":"Tam CW, Shiu SY (2011) Functional interplay between melatonin receptor-mediated antiproliferative signaling and androgen receptor signaling in human prostate epithelial cells: potential implications for therapeutic strategies against prostate cancer. J Pineal Res 51:297\u2013312. https:\/\/doi.org\/10.1111\/j.1600-079X.2011.00890.x","journal-title":"J Pineal Res"},{"key":"3617_CR55","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1034\/j.1600-079X.2003.00074.x","volume":"35","author":"SYW Shiu","year":"2003","unstructured":"Shiu SYW, Law IC, Lau KW, Tam PC, Yip AWC, Ng WT (2003) Melatonin slowed the early biochemical progression of hormone-refractory prostate cancer in a patient whose prostate tumor tissue expressed MT1 receptor subtype. J Pineal Res 35:177\u2013182. https:\/\/doi.org\/10.1034\/j.1600-079X.2003.00074.x","journal-title":"J Pineal Res"},{"key":"3617_CR56","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1600-079X.2012.01026.x","volume":"54","author":"SY Shiu","year":"2013","unstructured":"Shiu SY, Leung WY, Tam CW, Liu VW, Yao KM (2013) Melatonin MT1 receptor-induced transcriptional up-regulation of p27(Kip1) in prostate cancer antiproliferation is mediated via inhibition of constitutively active nuclear factor kappa B (NF-kappaB): potential implications on prostate cancer chemoprevention and therapy. J Pineal Res 54:69\u201379. https:\/\/doi.org\/10.1111\/j.1600-079X.2012.01026.x","journal-title":"J Pineal Res"},{"key":"3617_CR57","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2014.07.008","volume":"67","author":"LG Sigurdardottir","year":"2015","unstructured":"Sigurdardottir LG, Markt SC, Rider JR, Haneuse S, Fall K, Schernhammer ES, Tamimi RM, Flynn-Evans E, Batista JL, Launer L, Harris T, Aspelund T, Stampfer MJ, Gudnason V, Czeisler CA, Lockley SW, Valdimarsdottir UA, Mucci LA (2015) Urinary melatonin levels, sleep disruption, and risk of prostate cancer in elderly men. Eur Urol 67:191\u2013194. https:\/\/doi.org\/10.1016\/j.eururo.2014.07.008","journal-title":"Eur Urol"},{"key":"3617_CR58","doi-asserted-by":"publisher","first-page":"29606","DOI":"10.1038\/srep29606","volume":"6","author":"S-Y Tai","year":"2016","unstructured":"Tai S-Y, Huang S-P, Bao B-Y, Wu M-T (2016) Urinary melatonin-sulfate\/cortisol ratio and the presence of prostate cancer: a case-control study. Sci Rep 6:29606. https:\/\/doi.org\/10.1038\/srep29606","journal-title":"Sci Rep"},{"key":"3617_CR59","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/ijms19051505","volume":"19","author":"A Calastretti","year":"2018","unstructured":"Calastretti A, Gatti G, Lucini V, Dugnani S, Canti G, Scaglione F, Bevilacqua A (2018) Melatonin analogue antiproliferative and cytotoxic effects on human prostate cancer Cells. Int J Mol Sci 19:1505. https:\/\/doi.org\/10.3390\/ijms19051505","journal-title":"Int J Mol Sci"},{"key":"3617_CR60","doi-asserted-by":"publisher","first-page":"23074","DOI":"10.3390\/ijms151223074","volume":"15","author":"K Jab\u0142o\u0144ska","year":"2014","unstructured":"Jab\u0142o\u0144ska K, Pula B, Zemla A, Kobierzycki C, Kedzia W, Nowak-Markwitz E, Spaczynski M, Zabel M, Podhorska-Okolow M, Dziegiel P (2014) Expression of the MT1 melatonin receptor in ovarian cancer cells. Int J mol Sci 15:23074\u201323089","journal-title":"Int J mol Sci"},{"key":"3617_CR61","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3390\/ijms17020176","volume":"17","author":"C-J Shen","year":"2016","unstructured":"Shen C-J, Chang C-C, Chen Y-T, Lai C-S, Hsu Y-C (2016) Melatonin suppresses the growth of ovarian cancer cell lines (OVCAR-429 and PA-1) and potentiates the effect of G1 arrest by targeting CDKs. Int J Mol Sci 17:176","journal-title":"Int J Mol Sci"},{"key":"3617_CR62","doi-asserted-by":"publisher","first-page":"801","DOI":"10.21873\/invivo.11133","volume":"31","author":"A Zem\u0142a","year":"2017","unstructured":"Zem\u0142a A, Grzegorek I, Dzi\u0119giel P, Jab\u0142o\u0144ska K (2017) Melatonin synergizes the chemotherapeutic effect of cisplatin in ovarian cancer cells independently of MT1 melatonin receptors. In Vivo (Athens, Greece) 31:801\u2013809. https:\/\/doi.org\/10.21873\/invivo.11133","journal-title":"In Vivo (Athens, Greece)"},{"key":"3617_CR63","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1158\/1538-7445.am2015-94","volume":"75","author":"H Lee","year":"2015","unstructured":"Lee H, Jung JH, Lee HJ, Jeong MS, Jung D-B, Kwon HY, Kim S-H (2015) Abstract 94: melatonin inhibits stemness of glioblastoma cancer stem-like cells via regulation of histone methylation. Can Res 75:94. https:\/\/doi.org\/10.1158\/1538-7445.am2015-94","journal-title":"Can Res"},{"key":"3617_CR64","doi-asserted-by":"publisher","first-page":"245","DOI":"10.7150\/ijbs.16818","volume":"13","author":"X Zheng","year":"2017","unstructured":"Zheng X, Pang B, Gu G, Gao T, Zhang R, Pang Q, Liu Q (2017) Melatonin inhibits glioblastoma stem-like cells through suppression of EZH2-NOTCH1 signaling axis. Int J Biol Sci 13:245\u2013253. https:\/\/doi.org\/10.7150\/ijbs.16818","journal-title":"Int J Biol Sci"},{"key":"3617_CR65","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/jpi.12119","volume":"56","author":"Y Hong","year":"2014","unstructured":"Hong Y, Won J, Lee Y, Lee S, Park K, Chang K-T, Hong Y (2014) Melatonin treatment induces interplay of apoptosis, autophagy, and senescence in human colorectal cancer cells. J Pineal Res 56:264\u2013274. https:\/\/doi.org\/10.1111\/jpi.12119","journal-title":"J Pineal Res"},{"key":"3617_CR66","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/jpi.12226","volume":"58","author":"J-Y Wei","year":"2015","unstructured":"Wei J-Y, Li W-M, Zhou L-L, Lu Q-N, He W (2015) Melatonin induces apoptosis of colorectal cancer cells through HDAC4 nuclear import mediated by CaMKII inactivation. J Pineal Res 58:429\u2013438. https:\/\/doi.org\/10.1111\/jpi.12226","journal-title":"J Pineal Res"},{"key":"3617_CR67","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.21873\/anticanres.12437","volume":"38","author":"JH Lee","year":"2018","unstructured":"Lee JH, Yoon YM, Han YS, Yun CW, Lee SH (2018) Melatonin promotes apoptosis of oxaliplatin-resistant colorectal cancer cells through inhibition of cellular prion protein. Anticancer Res 38:1993\u20132000. https:\/\/doi.org\/10.21873\/anticanres.12437","journal-title":"Anticancer Res"},{"issue":"4","key":"3617_CR68","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/nu9040367","volume":"9","author":"X Meng","year":"2017","unstructured":"Meng X, Li Y, Li S, Zhou Y, Gan R-Y, Xu D-P, Li H-B (2017) Dietary sources and bioactivities of melatonin. Nutrients 9(4):367","journal-title":"Nutrients"},{"key":"3617_CR69","volume-title":"Cancer facts & figures\u00a02018","author":"American Cancer Society","year":"2018","unstructured":"American Cancer Society (2018) Cancer facts & figures\u00a02018. American Cancer Society, New York"},{"key":"3617_CR70","doi-asserted-by":"publisher","first-page":"39896","DOI":"10.18632\/oncotarget.16379","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Li S, Zhou Y, Meng X, Zhang J-J, Xu D-P, Li H-B (2017) Melatonin for the prevention and treatment of cancer. Oncotarget 8:39896\u201339921. https:\/\/doi.org\/10.18632\/oncotarget.16379","journal-title":"Oncotarget"},{"key":"3617_CR71","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1159\/000366305","volume":"34","author":"M Yun","year":"2014","unstructured":"Yun M, Kim EO, Lee D, Kim JH, Kim J, Lee H, Lee J, Kim SH (2014) Melatonin sensitizes H1975 non-small-cell lung cancer cells harboring a T790\u00a0M-targeted epidermal growth factor receptor mutation to the tyrosine kinase inhibitor gefitinib. Cell Physiol Biochem 34:865\u2013872. https:\/\/doi.org\/10.1159\/000366305","journal-title":"Cell Physiol Biochem"},{"key":"3617_CR72","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.18632\/oncotarget.6407","volume":"7","author":"J-J Lu","year":"2015","unstructured":"Lu J-J, Fu L, Tang Z, Zhang C, Qin L, Wang J, Yu Z, Shi D, Xiao X, Xie F, Huang W, Deng W (2015) Melatonin inhibits AP-2\u03b2\/hTERT, NF-\u03baB\/COX-2 and Akt\/ERK and activates caspase\/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells. Oncotarget 7:2985\u20133001. https:\/\/doi.org\/10.18632\/oncotarget.6407","journal-title":"Oncotarget"},{"key":"3617_CR73","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1152\/physrev.1998.78.3.687","volume":"78","author":"J Vanecek","year":"1998","unstructured":"Vanecek J (1998) Cellular mechanisms of melatonin action. Physiol Rev 78:687\u2013721. https:\/\/doi.org\/10.1152\/physrev.1998.78.3.687","journal-title":"Physiol Rev"},{"key":"3617_CR74","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3390\/molecules23030518","volume":"23","author":"WH Talib","year":"2018","unstructured":"Talib WH (2018) Melatonin and cancer hallmarks. Molecules 23:518. https:\/\/doi.org\/10.3390\/molecules23030518","journal-title":"Molecules"},{"key":"3617_CR75","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1159\/000438587","volume":"37","author":"W Li","year":"2015","unstructured":"Li W, Fan M, Chen Y, Zhao Q, Song C, Yan Y, Jin Y, Huang Z, Lin C, Wu J (2015) Melatonin induces cell apoptosis in AGS cells through the activation of JNK and P38 MAPK and the suppression of nuclear factor-kappa B: a novel therapeutic implication for gastric cancer. Cell Physiol Biochem 37:2323\u20132338. https:\/\/doi.org\/10.1159\/000438587","journal-title":"Cell Physiol Biochem"},{"key":"3617_CR76","doi-asserted-by":"publisher","first-page":"33756","DOI":"10.18632\/oncotarget.16808","volume":"8","author":"C-Y Yang","year":"2017","unstructured":"Yang C-Y, Lin C-K, Tsao C-H, Hsieh C-C, Lin G-J, Ma K-H, Shieh Y-S, Sytwu H-K, Chen Y-W (2017) Melatonin exerts anti-oral cancer effect via suppressing LSD1 in patient-derived tumor xenograft models. Oncotarget 8:33756\u201333769. https:\/\/doi.org\/10.18632\/oncotarget.16808","journal-title":"Oncotarget"},{"key":"3617_CR77","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.3892\/or.2018.6282","volume":"39","author":"J Song","year":"2018","unstructured":"Song J, Ma SJ, Luo JH, Zhang H, Wang RX, Liu H, Li L, Zhang ZG, Zhou RX (2018) Melatonin induces the apoptosis and inhibits the proliferation of human gastric cancer cells via blockade of the AKT\/MDM2 pathway. Oncol Rep 39:1975\u20131983. https:\/\/doi.org\/10.3892\/or.2018.6282","journal-title":"Oncol Rep"},{"key":"3617_CR78","doi-asserted-by":"publisher","first-page":"21952","DOI":"10.18632\/oncotarget.8009","volume":"7","author":"C-M Yeh","year":"2016","unstructured":"Yeh C-M, Lin C-W, Yang J-S, Yang W-E, Su S-C, Yang S-F (2016) Melatonin inhibits TPA-induced oral cancer cell migration by suppressing matrix metalloproteinase-9 activation through the histone acetylation. Oncotarget 7:21952\u201321967. https:\/\/doi.org\/10.18632\/oncotarget.8009","journal-title":"Oncotarget"},{"key":"3617_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3510970","volume":"2018","author":"Rui Liu H-lW","year":"2018","unstructured":"H-lW Rui Liu, Deng Man-jing, Wen Xiu-jie, Mo Yuan-yuan, Chen Fa-ming, Zou Chun-li, Duan Wei-feng, Li Lei, Nie Xin (2018) Melatonin Inhibits reactive oxygen species-driven proliferation, epithelial-mesenchymal transition, and vasculogenic mimicry in oral cancer. Oxid Med Cell Longev 2018:1\u201312. https:\/\/doi.org\/10.1155\/2018\/3510970","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"3617_CR80","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1042\/cs0940395","volume":"94","author":"N Webb","year":"1998","unstructured":"Webb N, Bottomley M, Watson CJ, Brenchley P (1998) vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF Levels in clinical disease. Clin Sci 94(4):395\u2013404","journal-title":"Clin Sci"},{"key":"3617_CR81","doi-asserted-by":"publisher","first-page":"46691","DOI":"10.18632\/oncotarget.17358","volume":"8","author":"C Chen","year":"2017","unstructured":"Chen C, Lou T (2017) Hypoxia inducible factors in hepatocellular carcinoma. Oncotarget 8:46691\u201346703. https:\/\/doi.org\/10.18632\/oncotarget.17358","journal-title":"Oncotarget"},{"key":"3617_CR82","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/bjc.2013.285","volume":"109","author":"S Carbajo-Pescador","year":"2013","unstructured":"Carbajo-Pescador S, Ordo\u00f1ez R, Benet M, Jover R, Garc\u00eda-Palomo A, Mauriz JL, Gonz\u00e1lez-Gallego J (2013) Inhibition of VEGF expression through blockade of Hif1\u03b1 and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells. Br J Cancer 109:83\u201391. https:\/\/doi.org\/10.1038\/bjc.2013.285","journal-title":"Br J Cancer"},{"key":"3617_CR83","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/jpi.12249","volume":"59","author":"R Ordo\u00f1ez","year":"2015","unstructured":"Ordo\u00f1ez R, Fern\u00e1ndez A, Prieto-Dom\u00ednguez N, Mart\u00ednez L, Garc\u00eda-Ruiz C, Fern\u00e1ndez-Checa JC, Mauriz JL, Gonz\u00e1lez-Gallego J (2015) Ceramide metabolism regulates autophagy and apoptotic cell death induced by melatonin in liver cancer cells. J Pineal Res 59:178\u2013189. https:\/\/doi.org\/10.1111\/jpi.12249","journal-title":"J Pineal Res"},{"key":"3617_CR84","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.18632\/oncotarget.6407","volume":"7","author":"JJ Lu","year":"2016","unstructured":"Lu JJ, Fu L, Tang Z, Zhang C, Qin L, Wang J, Yu Z, Shi D, Xiao X, Xie F, Huang W, Deng W (2016) Melatonin inhibits AP-2beta\/hTERT, NF-kappaB\/COX-2 and Akt\/ERK and activates caspase\/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells. Oncotarget 7:2985\u20133001. https:\/\/doi.org\/10.18632\/oncotarget.6407","journal-title":"Oncotarget"},{"key":"3617_CR85","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/ijms18040843","volume":"18","author":"R Reiter","year":"2017","unstructured":"Reiter R, Rosales-Corral S, Tan D-X, Acuna-Castroviejo D, Qin L, Yang S-F, Xu K (2017) Melatonin, a full service anti-cancer agent: inhibition of initiation, progression and metastasis. Int J Mol Sci 18:843","journal-title":"Int J Mol Sci"},{"key":"3617_CR86","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ydbio.2007.03.013","volume":"306","author":"JE Fata","year":"2007","unstructured":"Fata JE, Mori H, Ewald AJ, Zhang H, Yao E, Werb Z, Bissell MJ (2007) The MAPK(ERK-1,2) pathway integrates distinct and antagonistic signals from TGFalpha and FGF7 in morphogenesis of mouse mammary epithelium. Dev Biol 306:193\u2013207. https:\/\/doi.org\/10.1016\/j.ydbio.2007.03.013","journal-title":"Dev Biol"},{"key":"3617_CR87","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1600-079X.2007.00478.x","volume":"43","author":"P Subramanian","year":"2007","unstructured":"Subramanian P, Mirunalini S, Dakshayani KB, Pandi-Perumal SR, Trakht I, Cardinali DP (2007) Prevention by melatonin of hepatocarcinogenesis in rats injected with N-nitrosodiethylamine. J Pineal Res 43:305\u2013312. https:\/\/doi.org\/10.1111\/j.1600-079X.2007.00478.x","journal-title":"J Pineal Res"},{"key":"3617_CR88","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1002\/1097-0142(19940615)73:12<3015::AID-CNCR2820731220>3.0.CO;2-N","volume":"73","author":"B Neri","year":"1994","unstructured":"Neri B, Fiorelli C, Moroni F, Nicita G, Paoletti MC, Ponchietti R, Raugei A, Santoni G, Trippitelli A, Grechi G (1994) Modulation of human lymphoblastoid interferon activity by melatonin in metastatic renal cell carcinoma. A phase II study. Cancer 73:3015\u20133019","journal-title":"Cancer"},{"key":"3617_CR89","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1600-079X.2012.00975.x","volume":"53","author":"K-J Min","year":"2012","unstructured":"Min K-J, Kim H, Park EJ, Kwon TK (2012) Melatonin enhances thapsigargin-induced apoptosis through reactive oxygen species-mediated upregulation of CCAAT-enhancer-binding protein homologous protein in human renal cancer cells. J Pineal Res 53:99\u2013106","journal-title":"J Pineal Res"},{"key":"3617_CR90","first-page":"373","volume":"7","author":"AA Zamfir Chiru","year":"2014","unstructured":"Zamfir Chiru AA, Popescu CR, Gheorghe DC (2014) Melatonin and cancer. J Med Life 7:373\u2013374","journal-title":"J Med Life"},{"key":"3617_CR91","doi-asserted-by":"publisher","first-page":"e92627","DOI":"10.1371\/journal.pone.0092627","volume":"9","author":"HS Kim","year":"2014","unstructured":"Kim HS, Kim T-J, Yoo Y-M (2014) Melatonin combined with endoplasmic reticulum stress induces cell death via the PI3\u00a0K\/Akt\/mTOR pathway in B16F10 melanoma cells. PLoS ONE 9:e92627. https:\/\/doi.org\/10.1371\/journal.pone.0092627","journal-title":"PLoS ONE"},{"key":"3617_CR92","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.soncn.2016.05.005","volume":"32","author":"M Watson","year":"2016","unstructured":"Watson M, Holman DM, Maguire-Eisen M (2016) Ultraviolet radiation exposure and its impact on skin cancer risk. Semin Oncol Nurs 32:241\u2013254. https:\/\/doi.org\/10.1016\/j.soncn.2016.05.005","journal-title":"Semin Oncol Nurs"},{"key":"3617_CR93","doi-asserted-by":"publisher","first-page":"9789","DOI":"10.1158\/0008-5472.can-06-1776","volume":"66","author":"B Jung","year":"2006","unstructured":"Jung B, Ahmad N (2006) Melatonin in cancer management: progress and promise. Can Res 66:9789\u20139793. https:\/\/doi.org\/10.1158\/0008-5472.can-06-1776","journal-title":"Can Res"},{"key":"3617_CR94","doi-asserted-by":"publisher","first-page":"e99943","DOI":"10.1371\/journal.pone.0099943","volume":"9","author":"C Yi","year":"2014","unstructured":"Yi C, Zhang Y, Yu Z, Xiao Y, Wang J, Qiu H, Yu W, Tang R, Yuan Y, Guo W, Deng W (2014) Melatonin enhances the anti-tumor effect of fisetin by inhibiting COX-2\/iNOS and NF-kappaB\/p300 signaling pathways. PLoS ONE 9:e99943. https:\/\/doi.org\/10.1371\/journal.pone.0099943","journal-title":"PLoS ONE"},{"key":"3617_CR95","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1600-079X.2005.00305.x","volume":"40","author":"QH Yang","year":"2006","unstructured":"Yang QH, Xu JN, Xu RK, Pang SF (2006) Inhibitory effects of melatonin on the growth of pituitary prolactin-secreting tumor in rats. J Pineal Res 40:230\u2013235. https:\/\/doi.org\/10.1111\/j.1600-079X.2005.00305.x","journal-title":"J Pineal Res"},{"key":"3617_CR96","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/jpi.12298","volume":"60","author":"L Mao","year":"2015","unstructured":"Mao L, Dauchy R, Blask D, Dauchy E, Slakey L, Brimer S, Yuan L, Xiang S, Hauch A, Smith K, Frasch T, Belancio V, Wren M, Hill S (2015) Melatonin suppression of aerobic glycolysis (Warburg effect), survival signaling, and metastasis in human leiomyosarcoma. J Pineal Res 60:167\u2013177","journal-title":"J Pineal Res"},{"key":"3617_CR97","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.acthis.2016.02.004","volume":"118","author":"S Burattini","year":"2016","unstructured":"Burattini S, Battistelli M, Codenotti S, Falcieri E, Fanzani A, Salucci S (2016) Melatonin action in tumor skeletal muscle cells: an ultrastructural study. Acta Histochem 118:278\u2013285","journal-title":"Acta Histochem"},{"issue":"23","key":"3617_CR98","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.lfs.2013.10.012","volume":"93","author":"AP Batista","year":"2013","unstructured":"Batista AP, da Silva TG, Teixeira \u00c1A, de Medeiros PL, Teixeira VW, Alves LC, dos Santos FA (2013) Melatonin effect on the ultrastructure of Ehrlich ascites tumor cells, lifetime and histopathology in Swiss mice. Life Sci 93(23):882\u2013888","journal-title":"Life Sci"},{"key":"3617_CR99","first-page":"425","volume":"63","author":"K Danielczyk","year":"2009","unstructured":"Danielczyk K, Dziegiel P (2009) MT1 melatonin receptors and their role in the oncostatic action of melatonin. Postepy Hig Med Dosw (Online) 63:425\u2013434","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"3617_CR100","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1600-079X.2009.00727.x","volume":"48","author":"S Casado-Zapico","year":"2010","unstructured":"Casado-Zapico S, Rodriguez-Blanco J, Garcia-Santos G, Martin V, Sanchez-Sanchez AM, Antolin I, Rodriguez C (2010) Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway. J Pineal Res 48:72\u201380. https:\/\/doi.org\/10.1111\/j.1600-079X.2009.00727.x","journal-title":"J Pineal Res"},{"key":"3617_CR101","first-page":"2747","volume":"32","author":"A Cutando","year":"2012","unstructured":"Cutando A, Lopez-Valverde A, Arias-Santiago S, Dev J, Ded RG (2012) Role of melatonin in cancer treatment. Anticancer Res 32:2747\u20132753","journal-title":"Anticancer Res"},{"key":"3617_CR102","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/1534735411425484","volume":"11","author":"D Seely","year":"2011","unstructured":"Seely D, Wu P, Fritz H, Kennedy D, Tsui T, Seely A, Mills E (2011) Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials. Integr Cancer Ther 11:293\u2013303","journal-title":"Integr Cancer Ther"},{"key":"3617_CR103","first-page":"46","volume":"6","author":"S Malhotra","year":"2004","unstructured":"Malhotra S, Sawhney G, Pandhi P (2004) The therapeutic potential of melatonin: a review of the science. MedGenMed 6:46","journal-title":"MedGenMed"},{"key":"3617_CR104","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/j.1742-1241.2006.01191.x","volume":"61","author":"A Altun","year":"2007","unstructured":"Altun A, Ugur-Altun B (2007) Melatonin: therapeutic and clinical utilization. Int J Clin Pract 61:835\u2013845. https:\/\/doi.org\/10.1111\/j.1742-1241.2006.01191.x","journal-title":"Int J Clin Pract"},{"key":"3617_CR105","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1177\/030089169408000611","volume":"80","author":"P Lissoni","year":"1994","unstructured":"Lissoni P, Meregalli S, Fossati V, Paolorossi F, Barni S, Tancini G, Frigerio F (1994) A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancer. Tumori Journal 80:464\u2013467. https:\/\/doi.org\/10.1177\/030089169408000611","journal-title":"Tumori Journal"},{"key":"3617_CR106","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/bjc.1995.164","volume":"71","author":"P Lissoni","year":"1995","unstructured":"Lissoni P, Barni S, Meregalli S, Fossati V, Cazzaniga M, Esposti D, Tancini G (1995) Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. Br J Cancer 71:854\u2013856","journal-title":"Br J Cancer"},{"key":"3617_CR107","first-page":"1951","volume":"23","author":"G Cerea","year":"2003","unstructured":"Cerea G, Vaghi M, Ardizzoia A, Villa S, Bucovec R, Mengo S, Gardani G, Tancini G, Lissoni P (2003) Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations. Anticancer Res 23:1951\u20131954","journal-title":"Anticancer Res"},{"key":"3617_CR108","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000227465","volume":"52","author":"S Barni","year":"1995","unstructured":"Barni S, Lissoni P, Cazzaniga M, Ardizzoia A, Meregalli S, Fossati V, Fumagalli L, Brivio F, Tancini G (1995) A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates. Oncology 52:243\u2013245. https:\/\/doi.org\/10.1159\/000227465","journal-title":"Oncology"},{"key":"3617_CR109","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/oxfordjournals.annonc.a058391","volume":"4","author":"L Crino","year":"1993","unstructured":"Crino L, Latini P, Meacci M, Corgna E, Maranzano E, Darwish S, Minotti V, Santucci A, Tonato M (1993) Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer. Ann Oncol 4:847\u2013851","journal-title":"Ann Oncol"},{"key":"3617_CR110","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/sj.bjc.6690463","volume":"80","author":"M Ghielmini","year":"1999","unstructured":"Ghielmini M, Pagani O, de Jong J, Pampallona S, Conti A, Maestroni G, Sessa C, Cavalli F (1999) Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancer. Br J Cancer 80:1058\u20131061. https:\/\/doi.org\/10.1038\/sj.bjc.6690463","journal-title":"Br J Cancer"},{"key":"3617_CR111","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1600-079X.1997.tb00329.x","volume":"23","author":"P Lissoni","year":"1997","unstructured":"Lissoni P, Paolorossi F, Ardizzoia A, Barni S, Chilelli M, Mancuso M, Tancini G, Conti A, Maestroni GJ (1997) A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state. J Pineal Res 23:15\u201319","journal-title":"J Pineal Res"},{"key":"3617_CR112","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.otohns.2005.10.007","volume":"134","author":"UC Megwalu","year":"2006","unstructured":"Megwalu UC, Finnell JE, Piccirillo JF (2006) The effects of melatonin on tinnitus and sleep. Otolaryngol-Head Neck Surg 134:210\u2013213. https:\/\/doi.org\/10.1016\/j.otohns.2005.10.007","journal-title":"Otolaryngol-Head Neck Surg"},{"key":"3617_CR113","first-page":"660","volume":"34","author":"G Di Bella","year":"2013","unstructured":"Di Bella G, Mascia F, Ricchi A, Colori B (2013) Evaluation of the safety and efficacy of the first-line treatment with somatostatin combined with melatonin, retinoids, vitamin D3, and low doses of cyclophosphamide in 20 cases of breast cancer: a preliminary report. Neuro Endocrinol Lett 34:660\u2013668","journal-title":"Neuro Endocrinol Lett"},{"key":"3617_CR114","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10552-012-9927-8","volume":"23","author":"ES Schernhammer","year":"2012","unstructured":"Schernhammer ES, Giobbie-Hurder A, Gantman K, Savoie J, Scheib R, Parker LM, Chen WY (2012) A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkers. Cancer Causes Control 23:609\u2013616. https:\/\/doi.org\/10.1007\/s10552-012-9927-8","journal-title":"Cancer Causes Control"},{"key":"3617_CR115","doi-asserted-by":"publisher","DOI":"10.1042\/cs20180945","author":"C-C Chao","year":"2019","unstructured":"Chao C-C, Chen P-C, Chiou P-C, Hsu C-J, Liu P-Y, Yang Y-C, Reiter R, Yang S-F, Tang CH (2019) Melatonin suppresses lung cancer metastasis by inhibition of epithelial-mesenchymal transition through targeting to Twist. Clin Sci. https:\/\/doi.org\/10.1042\/cs20180945","journal-title":"Clin Sci"},{"key":"3617_CR116","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/tox.22674","volume":"34","author":"Y-C Yang","year":"2019","unstructured":"Yang Y-C, Chiou P-C, Chen P-C, Liu P-Y, Huang W-C, Chao C-C, Tang C-H (2019) Melatonin reduces lung cancer stemness through inhibiting of PLC, ERK, p38, \u03b2-catenin, and Twist pathways. Environ Toxicol 34:203\u2013209. https:\/\/doi.org\/10.1002\/tox.22674","journal-title":"Environ Toxicol"},{"key":"3617_CR117","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.3892\/ijo.2018.4586","volume":"53","author":"W Zhang","year":"2018","unstructured":"Zhang W, Liu K, Pei Y, Ma J, Tan J, Zhao J (2018) Mst1 regulates non-small cell lung cancer A549 cell apoptosis by inducing mitochondrial damage via ROCK1\/Factin pathways. Int J Oncol 53:2409\u20132422. https:\/\/doi.org\/10.3892\/ijo.2018.4586","journal-title":"Int J Oncol"},{"key":"3617_CR118","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.biopha.2018.10.097","volume":"109","author":"Y Xie","year":"2019","unstructured":"Xie Y, Lv Y, Zhang Y, Liang Z, Han L, Xie Y (2019) LATS2 promotes apoptosis in non-small cell lung cancer A549 cells via triggering Mff-dependent mitochondrial fission and activating the JNK signaling pathway. Biomed Pharmacother 109:679\u2013689. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.097","journal-title":"Biomed Pharmacother"},{"key":"3617_CR119","doi-asserted-by":"publisher","first-page":"e0195666","DOI":"10.1371\/journal.pone.0195666","volume":"13","author":"LW Chu","year":"2018","unstructured":"Chu LW, John EM, Yang B, Kurian AW, Zia Y, Yu K, Ingles SA, Stanczyk FZ, Hsing AW (2018) Measuring serum melatonin in postmenopausal women: implications for epidemiologic studies and breast cancer studies. PLoS ONE 13:e0195666. https:\/\/doi.org\/10.1371\/journal.pone.0195666","journal-title":"PLoS ONE"},{"key":"3617_CR120","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1158\/1538-7445.am2018-3915","volume":"78","author":"M Hasan","year":"2018","unstructured":"Hasan M, Marzouk MA, Adhikari S, Wright T, Miller B, Peckich B, Yingling S, Stratford R, Zlotos D, Cavanaugh J, Witt-Enderby P (2018) Abstract 3915: melatonin-tamoxifen hybrid ligands and their effects on breast cancer. Can Res 78:3915. https:\/\/doi.org\/10.1158\/1538-7445.am2018-3915","journal-title":"Can Res"},{"key":"3617_CR121","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3892\/ol.2018.9758","volume":"17","author":"NM Sonehara","year":"2019","unstructured":"Sonehara NM, Lacerda JZ, Jardim-Perassi BV, de Paula Jr R, Moschetta-Pinheiro MG, Souza YST, de Andrade JCJ, De Campos Zuccari DAP (2019) Melatonin regulates tumor aggressiveness under acidosis condition in breast cancer cell lines. Oncol Lett 17:1635\u20131645. https:\/\/doi.org\/10.3892\/ol.2018.9758","journal-title":"Oncol Lett"},{"key":"3617_CR122","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3892\/ijo.2017.4213","volume":"52","author":"C Alonso-Gonzalez","year":"2018","unstructured":"Alonso-Gonzalez C, Menendez-Menendez J, Gonzalez-Gonzalez A, Gonzalez A, Cos S, Martinez-Campa C (2018) Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF7 human breast cancer cells. Int J Oncol 52:560\u2013570. https:\/\/doi.org\/10.3892\/ijo.2017.4213","journal-title":"Int J Oncol"},{"key":"3617_CR123","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.lfs.2018.07.012","volume":"208","author":"JHM Marques","year":"2018","unstructured":"Marques JHM, Mota AL, Oliveira JG, Lacerda JZ, Stefani JP, Ferreira LC, Castro TB, Aristizabal-Pachon AF, Zuccari D (2018) Melatonin restrains angiogenic factors in triple-negative breast cancer by targeting miR-152-3p: in vivo and in vitro studies. Life Sci 208:131\u2013138. https:\/\/doi.org\/10.1016\/j.lfs.2018.07.012","journal-title":"Life Sci"},{"key":"3617_CR124","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgy186","author":"A Sakatani","year":"2018","unstructured":"Sakatani A, Sonohara F, Goel A (2018) Melatonin-mediated downregulation of thymidylate synthase as a novel mechanism for overcoming 5-fluorouracil associated chemoresistance in colorectal cancer cells. Carcinogenesis. https:\/\/doi.org\/10.1093\/carcin\/bgy186","journal-title":"Carcinogenesis"},{"key":"3617_CR125","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11010-017-3154-2","volume":"440","author":"R Pariente","year":"2018","unstructured":"Pariente R, Bejarano I, Rodr\u00edguez AB, Pariente JA, Espino J (2018) Melatonin increases the effect of 5-fluorouracil-based chemotherapy in human colorectal adenocarcinoma cells in vitro. Mol Cell Biochem 440:43\u201351. https:\/\/doi.org\/10.1007\/s11010-017-3154-2","journal-title":"Mol Cell Biochem"},{"key":"3617_CR126","doi-asserted-by":"publisher","first-page":"e12519","DOI":"10.1111\/jpi.12519","volume":"65","author":"JH Lee","year":"2018","unstructured":"Lee JH, Yun CW, Han Y-S, Kim S, Jeong D, Kwon HY, Kim H, Baek M-J, Lee SH (2018) Melatonin and 5-fluorouracil co-suppress colon cancer stem cells by regulating cellular prion protein-Oct4 axis. J Pineal Res 65:e12519. https:\/\/doi.org\/10.1111\/jpi.12519","journal-title":"J Pineal Res"},{"key":"3617_CR127","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4103\/1735-5362.223801","volume":"13","author":"N Ataei","year":"2018","unstructured":"Ataei N, Aghaei M, Panjehpour M (2018) The protective role of melatonin in cadmium-induced proliferation of ovarian cancer cells. Res Pharm Sci 13:159\u2013167. https:\/\/doi.org\/10.4103\/1735-5362.223801","journal-title":"Res Pharm Sci"},{"key":"3617_CR128","doi-asserted-by":"publisher","first-page":"17062","DOI":"10.1038\/s41598-017-16940-y","volume":"7","author":"M Akbarzadeh","year":"2017","unstructured":"Akbarzadeh M, Movassaghpour AA, Ghanbari H, Kheirandish M, Fathi Maroufi N, Rahbarghazi R, Nouri M, Samadi N (2017) The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells. Sci Rep 7:17062. https:\/\/doi.org\/10.1038\/s41598-017-16940-y","journal-title":"Sci Rep"},{"key":"3617_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11626-017-0200-z","volume":"54","author":"L Chen","year":"2018","unstructured":"Chen L, Liu L, Li Y, Gao J (2018) Melatonin increases human cervical cancer HeLa cells apoptosis induced by cisplatin via inhibition of JNK\/Parkin\/mitophagy axis. In Vitro Cell Dev Biol 54:1\u201310. https:\/\/doi.org\/10.1007\/s11626-017-0200-z","journal-title":"In Vitro Cell Dev Biol"},{"key":"3617_CR130","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3390\/ijms18061130","volume":"18","author":"VWS Liu","year":"2017","unstructured":"Liu VWS, Yau WL, Tam CW, Yao K-M, Shiu SYW (2017) Melatonin inhibits androgen receptor splice variant-7 (AR-V7)-induced nuclear factor-kappa B (NF-\u03baB) activation and NF-\u03baB Activator-induced AR-V7 expression in prostate cancer cells: potential implications for the use of melatonin in castration-resistant prostate cancer (CRPC) therapy. Int J Mol Sci 18:1130","journal-title":"Int J Mol Sci"},{"key":"3617_CR131","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7150\/jca.9591","volume":"6","author":"EJ Sohn","year":"2015","unstructured":"Sohn EJ, Won G, Lee J, Lee S, Kim S-H (2015) Upregulation of miRNA3195 and miRNA374b mediates the anti-angiogenic properties of melatonin in hypoxic PC-3 prostate cancer cells. J Cancer 6:19\u201328. https:\/\/doi.org\/10.7150\/jca.9591","journal-title":"J Cancer"},{"key":"3617_CR132","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/pros.10098","volume":"52","author":"SWF Siu","year":"2002","unstructured":"Siu SWF, Lau KW, Tam PC, Shiu SYW (2002) Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity. Prostate 52:106\u2013122. https:\/\/doi.org\/10.1002\/pros.10098","journal-title":"Prostate"},{"key":"3617_CR133","doi-asserted-by":"publisher","first-page":"e12480","DOI":"10.1111\/jpi.12480","volume":"65","author":"J Zibolka","year":"2018","unstructured":"Zibolka J, Bazwinsky-Wutschke I, M\u00fchlbauer E, Peschke E (2018) Distribution and density of melatonin receptors in human main pancreatic islet cell types. J Pineal Res 65:e12480. https:\/\/doi.org\/10.1111\/jpi.12480","journal-title":"J Pineal Res"},{"key":"3617_CR134","first-page":"665","volume":"29","author":"TW Fischer","year":"2006","unstructured":"Fischer TW, Zmijewski MA, Zbytek B, Sweatman TW, Slominski RM, Wortsman J, Slominski A (2006) Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines. Int J Oncol 29:665\u2013672","journal-title":"Int J Oncol"},{"key":"3617_CR135","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/jpi.12298","volume":"60","author":"L Mao","year":"2016","unstructured":"Mao L, Dauchy RT, Blask DE, Dauchy EM, Slakey LM, Brimer S, Yuan L, Xiang S, Hauch A, Smith K, Frasch T, Belancio VP, Wren MA, Hill SM (2016) Melatonin suppression of aerobic glycolysis (Warburg effect), survival signalling and metastasis in human leiomyosarcoma. J Pineal Res 60:167\u2013177. https:\/\/doi.org\/10.1111\/jpi.12298","journal-title":"J Pineal Res"},{"key":"3617_CR136","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/jpi.12308","volume":"60","author":"Y-W Lin","year":"2016","unstructured":"Lin Y-W, Lee L-M, Lee W-J, Chu C-Y, Tan P, Yang Y-C, Chen W-Y, Yang S-F, Hsiao M, Chien M-H (2016) Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-\u03baB DNA-binding activity. J Pineal Res 60:277\u2013290. https:\/\/doi.org\/10.1111\/jpi.12308","journal-title":"J Pineal Res"},{"key":"3617_CR137","doi-asserted-by":"publisher","DOI":"10.1002\/ar.24101","author":"J Song","year":"2019","unstructured":"Song J, Ma S-J, Luo J-H, Liu H, Li L, Zhang Z-G, Chen L-S, Zhou R-X (2019) Down-regulation of AKT and MDM2, Melatonin induces apoptosis in AGS and MGC803 cells. Anat Rec. https:\/\/doi.org\/10.1002\/ar.24101","journal-title":"Anat Rec"},{"key":"3617_CR138","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00520-015-2883-6","volume":"24","author":"PF Innominato","year":"2016","unstructured":"Innominato PF, Lim AS, Palesh O, Clemons M, Trudeau M, Eisen A, Wang C, Kiss A, Pritchard KI, Bjarnason GA (2016) The effect of melatonin on sleep and quality of life in patients with advanced breast cancer. Support Care Cancer 24:1097\u20131105. https:\/\/doi.org\/10.1007\/s00520-015-2883-6","journal-title":"Support Care Cancer"},{"key":"3617_CR139","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1600-079X.2005.00258.x","volume":"39","author":"E Mills","year":"2005","unstructured":"Mills E, Wu P, Seely D, Guyatt G (2005) Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis. J Pineal Res 39:360\u2013366. https:\/\/doi.org\/10.1111\/j.1600-079X.2005.00258.x","journal-title":"J Pineal Res"},{"key":"3617_CR140","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1034\/j.1600-0633.2002.290401.x","volume":"29","author":"MdLV Seabra","year":"2000","unstructured":"Seabra MdLV, Bignotto M, Pinto LR Jr, Tufik S (2000) Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J Pineal Res 29:193\u2013200. https:\/\/doi.org\/10.1034\/j.1600-0633.2002.290401.x","journal-title":"J Pineal Res"},{"key":"3617_CR141","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1177\/1534735411425484","volume":"11","author":"D Seely","year":"2012","unstructured":"Seely D, Wu P, Fritz H, Kennedy DA, Tsui T, Seely AJE, Mills E (2012) Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials. Integr Cancer Ther 11:293\u2013303. https:\/\/doi.org\/10.1177\/1534735411425484","journal-title":"Integr Cancer Ther"},{"key":"3617_CR142","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1159\/000226978","volume":"48","author":"P Lissoni","year":"1991","unstructured":"Lissoni P, Barni S, Cattaneo G, Tancini G, Esposti G, Esposti D, Fraschini F (1991) Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies. Oncology 48:448\u2013450. https:\/\/doi.org\/10.1159\/000226978","journal-title":"Oncology"},{"key":"3617_CR143","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1080\/17425255.2018.1513492","volume":"14","author":"H Haghi-Aminjan","year":"2018","unstructured":"Haghi-Aminjan H, Farhood B, Rahimifard M, Didari T, Baeeri M, Hassani S, Hosseini R, Abdollahi M (2018) The protective role of melatonin in chemotherapy-induced nephrotoxicity: a review of non-clinical studies. Expert Opin Drug Metab Toxicol 14:937\u2013950. https:\/\/doi.org\/10.1080\/17425255.2018.1513492","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3617_CR144","doi-asserted-by":"publisher","first-page":"6007","DOI":"10.1200\/jco.2018.36.15_suppl.6007","volume":"36","author":"A Lozano","year":"2018","unstructured":"Lozano A, Marruecos J, Rubi\u00f3-Casadevall J, Farre N, Lopez-Pousa A, Giralt J, Planas I, Cirauqui B, Lanzuela M, Morera R, Escribano A, Gomez-Millan J, Toledo MD, Masedo GV, Cascallar L, Grima P, Valenti V, Tarrago C, Bosser R (2018) Mesia R and Study M Phase II trial of high-dose melatonin oral gel for the prevention and treatment of oral mucositis in H&N cancer patients undergoing chemoradiation (MUCOMEL). J Clin Oncol 36:6007. https:\/\/doi.org\/10.1200\/jco.2018.36.15_suppl.6007","journal-title":"J Clin Oncol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03617-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-019-03617-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03617-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T11:42:47Z","timestamp":1610883767000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-019-03617-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,26]]},"references-count":144,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3617"],"URL":"https:\/\/doi.org\/10.1007\/s11010-019-03617-5","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,26]]},"assertion":[{"value":"11 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}